2-Hydroxyquinoline - CAS 59-31-4
Catalog: |
BB030339 |
Product Name: |
2-Hydroxyquinoline |
CAS: |
59-31-4 |
Synonyms: |
2(1H)-Quinolinone; Carbostyril; 1,2-Dihydro-2-oxoquinoline; 2(1H)-Quinolone; 2-Oxo-1,2-dihydroquinoline; 2-Quinolinol; 2-Quinolinone; 2-Quinolone; NSC 156783; NSC 554; NSC 97217; o-Aminocinnamic acid lactam; α-Hydroxyquinoline; α-Quinolone |
Related CAS: | 493-62-9 (Deleted CAS)
|
IUPAC Name: | 1H-quinolin-2-one |
Description: | 2-Hydroxyquinoline is a natural product found in Houttuynia cordata, Aconitum ferox, and Glycosmis pentaphylla. |
Molecular Weight: | 145.16 |
Molecular Formula: | C9H7NO |
Canonical SMILES: | C1=CC=C2C(=C1)C=CC(=O)N2 |
InChI: | InChI=1S/C9H7NO/c11-9-6-5-7-3-1-2-4-8(7)10-9/h1-6H,(H,10,11) |
InChI Key: | LISFMEBWQUVKPJ-UHFFFAOYSA-N |
Boiling Point: | 346.7±35.0°C at 760 mmHg |
Melting Point: | 199.5°C |
Purity: | ≥95% |
Density: | 1.188±0.06 g/cm3 |
Solubility: | Soluble in Alcohol |
Appearance: | White to light purple or purple-brownish powder |
Storage: | Store at RT |
MDL: | MFCD00006743 |
LogP: | 1.52810 |
GHS Hazard Statement: | H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation] |
Precautionary Statement: | P261, P264, P271, P280, P302+P352, P304+P340, P305+P351+P338, P312, P321, P332+P313, P337+P313, P362, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
US-11021531-B1 | Anti-SARS-Cov-2 antibodies derived from 2GHW | 20200323 |
US-11021532-B1 | Superhuman anti-SARS-CoV-2 antibodies and uses thereof | 20200323 |
US-11028150-B1 | Anti-SARS-CoV-2 antibodies derived from 2DD8 | 20200323 |
US-11028167-B1 | Anti-SARS-Cov-2 antibodies derived from 3bgf | 20200323 |
US-11034762-B1 | Anti-SARS-Cov-2 antibodies derived from CR3022 | 20200323 |
PMID | Publication Date | Title | Journal |
32109484 | 20200401 | Molecular mechanisms of apoptosis induced by a novel synthetic quinolinone derivative in HL-60 human leukemia cells | Chemico-biological interactions |
31836637 | 20200201 | Multi-omic Characterization of the Mode of Action of a Potent New Antimalarial Compound, JPC-3210, Against Plasmodium falciparum | Molecular & cellular proteomics : MCP |
31744901 | 20200107 | An sRNA Screen for Reversal of Quinolone Resistance in Escherichia coli | G3 (Bethesda, Md.) |
31005593 | 20190615 | Effects of TNFR1 gene silencing on early apoptosis of marbofloxacin-treated chondrocytes from juvenile dogs | Toxicology |
31022492 | 20190615 | HHQ-4, a quinoline derivate, preferentially inhibits proliferation of glucose-deprived breast cancer cells as a GRP78 down-regulator | Toxicology and applied pharmacology |
Complexity: | 198 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 145.052763847 |
Formal Charge: | 0 |
Heavy Atom Count: | 11 |
Hydrogen Bond Acceptor Count: | 1 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 145.052763847 |
Rotatable Bond Count: | 0 |
Topological Polar Surface Area: | 29.1 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 1.3 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Quinoline/Isoquinoline
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS